For the Inventor, By the Inventor

Enter assignee name

Freising-Weihenstephan, Germany

Pieris Ag

USPTO Granted Patents = 16

CIPO Patents = 3

EPO Patents = 4

Trademarks = 2

Forward Citations = 310

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Arne Skerra (12 out of 40 patents)

Andreas Hohlbaum (8 out of 22 patents)

Steffen Schlehuber (7 out of 10 patents)

4. Gabriele Matschiner (6 out of 21 patents)

5. Kristian Hobolt Jensen (4 out of 16 patents)

6. Martin Huelsmeyer (4 out of 12 patents)

7. Gerald Beste (4 out of 4 patents)

8. Frank Schmidt (4 out of 6 patents)

9. Thomas Stibora (4 out of 4 patents)

10. Stefan Trentmann (3 out of 9 patents)

11. Hans-Juergen Christian (2 out of 5 patents)

12. Eric Boudreau (2 out of 8 patents)

13. Richard Jones (2 out of 3 patents)

14. Ian Kimber (2 out of 3 patents)

15. Rebecca Dearman (2 out of 3 patents)

16 patents: Sort by Forward Citations

1. 9260492 - Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3) (2016-02-16),

2. 9221887 - Muteins of tear lipocalin and methods for obtaining the same (2015-12-29),

3. 9221885 - Muteins of human lipocalin 2 with affinity for CTLA-4 (2015-12-29),

4. 9212208 - Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the same (2015-12-15),

5. 9051382 - Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such (2015-06-09),

6. 8986951 - Tear lipocalin in muteins binding IL-4 R alpha (2015-03-24),

7. 8536307 - Anticalins (2013-09-17),

8. 8313924 - Muteins of tear lipocalin and methods for obtaining the same (2012-11-20),

9. 8158753 - Anticalins (2012-04-17),

10. 7893208 - Muteins of human tear lipocalin (2011-02-22),

11. 7892827 - Compound with affinity for the cytotoxic T lymphocyte-associated antigen (CTLA-4) (2011-02-22),

12. 7723476 - Anticalins (2010-05-25),

13. 7691970 - Muteins of a bilin-binding protein with affinity for a given target (2010-04-06),

14. 7585940 - Muteins of human tear lipocalin (2009-09-08),

15. 7252998 - Muteins of human neutrophil gelatinase-associated lipocalin and related proteins (2007-08-07),

Pieris AG is a biotechnology company specializing in the discovery and development of Anticalin proteins. Anticalins are a unique class of engineered proteins that can be used for various therapeutic and diagnostic applications. With a focus on developing innovative solutions for cancer, respiratory, and autoimmune diseases, Pieris AG aims to improve patient outcomes and quality of life. Visit their website for more information.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

16 Patents

#1 in Freising-Weihenstephan

#2,632 in Germany

#36,684 in the World

Freising-Weihenstephan, Germany

Pieris Ag

Forward Citations = 310

21 inventors:

Arne Skerra (12 out of 40 patents)

Andreas Hohlbaum (8 out of 22 patents)

Steffen Schlehuber (7 out of 10 patents)

4. Gabriele Matschiner (6 out of 21 patents)

5. Kristian Hobolt Jensen (4 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…